血小板因子4限制了中性粒细胞外细胞陷和无细胞DNA诱导的血栓性和内皮损伤
Anh Tp Ngo1, Abigail Skidmore1, Jenna Oberg1
1Division of Hematology, Children's Hospital of Philadelphia, Philadelphia, Pennsylvania, USA.
JCI insight
|November 22, 2023
概括
血小板因子4 (PF4) 在败血症中稳定无细胞DNA (cfDNA) 和中性粒细胞外细胞陷 (NETs). 这种新的方法可以预防血栓形成和内皮损伤,为败血症治疗提供了潜在的治疗策略.
科学领域:
- 生物医学研究的研究.
- 免疫学 免疫学 免疫学
- 血液学 血液学 血液学
背景情况:
- 无血细胞DNA (cfDNA) 是败血症严重性标志物和血栓炎症的驱动因素.
- 中性细胞外细胞陷 (NETs) 是败血症中cfDNA的主要来源.
- 目前的NET向策略存在局限性,可能会加剧血栓形成和内皮损伤.
研究的目的:
- 为了研究化学基因血小板因子4 (PF4,CXCL4) 作为败血症的治疗剂.
- 评估PF4稳定cfDNA和NET的能力,减轻它们的促血栓和内皮损伤作用.
主要方法:
- 在体外实验中评估PF4与cfDNA和NETs的相互作用.
- 在体外评估cfDNA诱导的内皮激活 (组织因子表达,·维勒布兰德因子释放).
- 在体内研究中,使用动物模型进行cfDNA输注和脂多糖化物挑战,测量血-抗血 (TAT) 水平.
主要成果:
- PF4可以防止cfDNA和NET分裂成血栓形成的碎片.
- 在体外,PF4抑制cfDNA诱导的内皮组织因子表达和威莱布兰德因子释放.
- 在小鼠中,PF4的使用降低了体内血TAT水平,并改善了败血症诱导的血栓炎症和器官损伤标志物.
结论:
- PF4与cfDNA和NET相互作用,以限制血栓形成和内皮损伤.
- 通过稳定cfDNA和NETs,PF4代表了治疗败血症的有希望的治疗策略.
- 这种方法为管理与败血症相关的血栓炎症提供了一种新的方法.
相关概念视频
01:22Formation of the Platelet Plug
6.5K
The platelet phase, the second stage of hemostasis, commences around 15-20 seconds after an injury. It follows and overlaps with the vascular phase, during which blood vessels constrict to minimize blood loss.
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
As the injured blood vessel contracts, endothelial cells undergo contraction, revealing collagen fibers in the basement membrane and underlying connective tissue. Furthermore, the plasma membrane of endothelial cells becomes adhesive, preparing the site for platelet adhesion. Platelets...
6.5K
01:16Clot Retraction and Fibrinolysis
6.2K
After a fibrin clot is formed, the next step is clot retraction, a vital process facilitated by platelet contractile proteins, such as actin and myosin. These proteins pull the fibrin strands closer together and condense the clot. This action reduces the size of the clot, creating a smaller, denser structure that effectively seals off the damaged vessel. Clot retraction consolidates the clot and helps with wound healing by bringing the edges of the damaged blood vessel closer together.
6.2K
01:20Extrinsic and Intrinsic Pathways of Hemostasis
8.0K
Blood clotting or coagulation involves extrinsic and intrinsic pathways, which ultimately merge into the common pathway, forming a fibrin clot.
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
The Extrinsic Pathway
The extrinsic pathway of coagulation is typically initiated by tissue damage that exposes blood to tissue factor (TF), a protein released by the damaged tissue cells outside the blood vessels—this interaction with TF triggers biochemical reactions involving specific clotting factors. The key player here is Factor VII, which...
8.0K
01:30Anticoagulant Drugs: Low-Molecular-Weight Heparins
713
Hemostasis is a crucial process that prevents excessive blood loss from damaged blood vessels. It involves various mechanisms such as vasoconstriction, platelet adhesion and activation, and fibrin formation. The importance of each mechanism depends on the type of vessel injury. In contrast, thrombosis is the abnormal formation of a blood clot within the blood vessels, leading to potential complications if the clot obstructs blood flow. Thrombosis can be caused by increased coagulability of the...
713
01:18Structure and Function of Platelets
1.2K
The cell fragments known as platelets are disc-shaped, with an average diameter of about 3 μm and a thickness of roughly 1 μm. They play a crucial role in the body's vascular clotting system, which also involves plasma proteins, blood cells, and blood vessel tissues.
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
Platelets are continually replenished, circulating in the bloodstream for 9-12 days before being removed by phagocytes, primarily in the spleen. A microliter of circulating blood contains between 150,000 and 450,000...
1.2K
01:17Intracellular Signaling Affects Focal Adhesions
2.7K
Integrins act both as extracellular input receivers and as intracellular processing activators. As their name suggests, integrins are entirely integrated into the membrane structure. Their hydrophobic membrane-spanning regions interact with the phospholipid bilayer's hydrophobic region. These membrane receptors provide extracellular attachment sites for effectors like hormones and growth factors. They activate intracellular response cascades when their effectors are bound and active.
Some...
Some...
2.7K